Steven Sugarman

Steven Sugarman

Memorial Sloan Kettering Cancer Center - Indore / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4441334
person_outline Steven Sugarman's MOST POPULAR ARTICLES
1-) HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing …S Modi, A Stopeck, H Linden, D Solit, S Chandarlapaty, N Rosen, ...Clinical Cancer Research 17 (15), 5132-5139, 20114822011
2-) Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancerAW Tolcher, S Sugarman, KA Gelmon, R Cohen, M Saleh, C Isaacs, ...Journal of Clinical Oncology 17 (2), 478-478, 19993181999
3-) Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.R Pazdur, Y Lassere, V Rhodes, JA Ajani, SM Sugarman, YZ Patt, ...Journal of clinical oncology 12 (11), 2296-2300, 19942651994
4-) Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patientsG Deng, AJ Vickers, KS Yeung, GM D\'Andrea, H Xiao, AS Heerdt, ...Journal of Clinical Oncology 25 (35), 5584-5590, 20072562007
5-) Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinibPG Morris, C Chen, R Steingart, M Fleisher, N Lin, B Moy, S Come, ...Clinical Cancer Research 17 (10), 3490-3499, 20111572011